Literature DB >> 11507321

Cholesteryl ester transfer protein, high density lipoprotein and arterial disease.

P J Barter1, K A Rye.   

Abstract

The reported relationships between cholesteryl ester transfer protein, high density lipoproteins and arterial disease are confusing and conflicting. Several papers published during the review period add substantially to the evidence base regarding the atherogenicity (or anti-atherogenicity) of cholesteryl ester transfer protein, although none clearly resolves the continuing conflict. These new papers are presented against the backdrop of the previous state of knowledge.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11507321     DOI： 10.1097/00041433-200108000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


  6 in total

1.  Association between TaqIB polymorphism of cholesteryl ester transfer protein and coronary artery disease in the Chinese population.

Authors:  Qi Yu; En-qi Liu; Si-hai Zhao; Ya-feng Li; Yan-li Wang; Yu-long Chen; Ke-na Wei; Bing-qiao Huang; Jian-lin Fan; Peng-hui Yang
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

2.  The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering.

Authors:  Zhiping Wu; Valentin Gogonea; Xavier Lee; Roland P May; Vitaliy Pipich; Matthew A Wagner; Arundhati Undurti; Thomas C Tallant; Camelia Baleanu-Gogonea; Francesca Charlton; Alexander Ioffe; Joseph A DiDonato; Kerry-Anne Rye; Stanley L Hazen
Journal:  J Biol Chem       Date:  2011-02-03       Impact factor: 5.157

3.  Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.

Authors:  Anne Braun; Ayce Yesilaltay; Susan Acton; Kay O Broschat; Elaine S Krul; Nida Napawan; Nancy Stagliano; Monty Krieger
Journal:  Atherosclerosis       Date:  2007-12-03       Impact factor: 5.162

4.  Modulation of human postprandial lipemia by changing ratios of polyunsaturated to saturated (P/S) fatty acid content of blended dietary fats: a cross-over design with repeated measures.

Authors:  Tilakavati Karupaiah; Kalyana Sundram
Journal:  Nutr J       Date:  2013-08-16       Impact factor: 3.271

5.  Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population.

Authors:  Yongjian Lu; Naeimeh Tayebi; Hongzhe Li; Nilmani Saha; Hongyuan Yang; Chew-Kiat Heng
Journal:  Lipids Health Dis       Date:  2013-06-08       Impact factor: 3.876

6.  Use of bile correction factors for allometric prediction of human pharmacokinetic parameters of torcetrapib, a facile cholesteryl ester transfer protein inhibitor.

Authors:  Ramesh Mullangi; Preeti Ahlawat; Ravi K Trivedi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jan-Mar       Impact factor: 2.569
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.